AMES, Iowa, Sept. 6 BioForce Nanosciences (OTC Bulletin Board: BFNH.OB), a leader in nanotechnology tools and products, has named Gabor Bethlendy Sales Manager for Europe. He will be
based in Boston, Massachusetts.
Bethlendy joins BioForce from Combimatrix Corp., where he was the Regional Sales Manager for the custom microarray and array synthesizer product lines. Prior to this, Bethlendy was the Sr. Application Scientist for Agilent Technologies responsible for the entire genomics product line
from reagents to informatics. He played a critical role in the development of the CGH and ChIP-ChIP business for Agilent in the Boston community. He will assist BioForce's European distributor (Nanoandmore) and the United Kingdom distributor (Windsor Scientific) to identify and secure additional installations in these regions for the Nano eNabler(TM) system, the
company's signature product.
The premier product, the Nano eNabler(TM) benchtop molecular printing system, places tiny domains of biological materials on surfaces with nanometer spatial precision. This spring BioForce placed a Nano eNabler(TM) system in Paris at the Universite Pierre & Marie Curie (UPMC) where
researchers are using the printer for cell protein patterning. The Institute of Biomedical Chemistry in Moscow, Russia, is using the system to immobilize proteins and peptides on Sindex(TM) chips for nanoscale detection and analysis. Bethlendy commented, "I am excited about the
leading institutions that have decided to partner with us and look forward to leveraging these relationships into product improvements and sales."
"We recently attended the International Conference on Nanoscience and Technology in Basel, Switzerland, where we engaged in productive discussions with key distributors," said Kerry Frey, BioForce Chief Operating Officer. "Gabor will work with BioForce customers and distributors in Europe and the United Kingdom, and spearhead our effort there to identify other potential installations for our product. We are pleased to welcome him to the company."
About BioForce Nanosciences, Inc.
BioForce Nanosciences is a nanotechnology tools and applications company, providing innovative and practical products that support the growth of the nanotechnology industry. The company has spent more than a decade of invention, research and development on patented and patent-pending nanotechnology products. The core technology is the Nano eNabler(TM) Benchtop Molecular Printer, a portal to new opportunities in nanotechnology. The Nano eNabler(TM) system opens the door to new and important applications in the biomedical and life sciences markets that lead to improved quality of life. BioForce continues to target inventions that further expand the reach of its proprietary technology and its robust patent, trademark and IP portfolio.
BioForce Nanosciences, Inc., the Practical Nanotechnology(TM) company, brings inventions to the marketplace that complement existing innovations, licensing opportunities and acquisitions. BioForce is a wholly owned subsidiary of BioForce Nanosciences Holdings, Inc. (OTC BB: BFNH.OB). For more information, visit http://www.bioforcenano.com.
This news release contains forward-looking information that may be affected by certain risks and uncertainties, including those risks and uncertainties described in the company's most recent filings with the Securities and Exchange Commission. The company's actual results could differ materially from such forward-looking statements. We assume no duty to update these statements at any future date.
SOURCE BioForce Nanosciences, Inc. PRNewswire-FirstCall
Posted
on : Wed, 06 Sep 2006 13:36 GMT | Business News
By : BioForce Nanosciences, Inc.
|
